Why would you think that? There is nothing to suggest they are scrambling to collect more data. The trial was designed for 28 days, they followed it and at the halfway point, the DCMB said continue as planned with no changes. The fact that Nader gave a 2-3 week timeline for concluding discussions tells us that there is no need to go back and get more data, it would take longer than 2-3 weeks to do that and when this timeline was given (last Monday). Nader knew what the data showed. If the data lead to the idea that the FDA would need more data, the timeline would have been longer. Even if Nader's timelines are too optimistic, there is no way Nader would suggest that in 2-3 weeks they would add 42 and 60 day trial data for 394 patients.
The PR from the FDA was focused on other treatments that are more directly treating the virus and it's spike protein. I think the FDA is working hard to get these other treatments to work together and broaden their trials because they know we are moving into treating the other varients of Covid. The FDA wants the industry to work together ASAP. Vyrologix is not targeting the specific virus, so they are not part of that. The very fact that PR from the FDA came out the same day Cytodyn announce their data has been sent to them kind of proves they are not related to each other. Do you really think Nader and the FDA called each other to coordinate cryptic PR's?
Sometimes things are just too obvious and reading into things is unnecessary. IMO.